Simbatec Tablet (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.
MFDS item code 200402028 · Notified 2004.09.23
This product's status changed to Expired on 2024.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases. In particular, it lowers the risk of death from heart disease and myocardial infarction, as well as stroke in patients with a history of coronary heart disease, diabetes, peripheral vascular disease, or stroke. It also reduces risks associated with vascular surgeries. It plays an important role in treating hyperlipidemia, improving blood cholesterol and triglyceride levels in patients with primary and familial hypercholesterolemia, and increasing HDL cholesterol. In pediatric patients with heterozygous familial hypercholesterolemia, it effectively controls cholesterol levels when used in conjunction with dietary therapy. Therefore, this medication is used to maintain cardiovascular health and treat hyperlipidemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events because of a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before treatment, the treatment target, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this drug, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this drug once daily in the evening. This drug may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this drug must not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this drug must not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This drug is effective when used alone or in combination with bile acid sequestrants. When this drug is administered concomitantly with fibrates (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this drug must not exceed 10 mg per day. (6) Use in patients with renal impairment Because this drug is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor closely.
Ages 10 ~ 17: The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or longer between dose adjustments.
This medication carries a risk of muscle abnormalities, particularly when taken at high doses or in conjunction with certain medications, which can cause muscle damage. It may affect liver function, so patients with liver disease or impaired liver function should avoid using it. Regular liver function tests are recommended. Women who are pregnant or may become pregnant, as well as nursing women, should not take this medication. If pregnancy is confirmed, the medication should be discontinued immediately. This drug may cause interactions if taken with specific other medications, increasing the risk of side effects, especially with some antibiotics, antifungals, immunosuppressants, and calcium channel blockers. Caution is required when prescribing to the elderly, patients with decreased kidney function, or patients with hypothyroidism, and any occurrence of muscle pain or weakness should prompt immediate consultation with a doctor. If unexplained muscle pain, tenderness, or weakness occurs during treatment, it should be reported to a doctor immediately, and if these symptoms worsen or persist, discontinuation may be necessary. During treatment, the intake of certain foods such as grapefruit juice must be limited, and large quantities of grapefruit juice should be avoided. Moreover, when administering this medication to children and adolescents, it should be used cautiously considering age and growth status, and it is not to be used in children under 10 years of age. In case of overdose, seek medical attention immediately for appropriate treatment. Lastly, this medication should be stored out of reach of children and kept safely in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture and should be kept in a tightly closed container. It is essential to maintain a storage temperature between 1 °C and 30 °C.
Light yellow oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Simvastatin 20mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.